How We Help
MMIT's industry-leading P&T panel consists of pharmacy decision-makers at health plans, PBMs, providers and integrated delivery systems. 100% of panelists are either active P&T participants or control access for pharmaceuticals for their organizations, giving you unparalleled visibility into these entities.
Simulate a typical payer or IDN P&T committee, including a pharmacy director, medical director, contracting executives, and physicians and disease state specialists.
Analyze a clinical dossier developed autonomously by a clinical pharmacist, with the opportunity to provide additional clinical data and/or target product profile.
Observe a 90 minute live-streamed session, including a 45 minute clinical overview and discussion based on the clinical dossier and a 45 minute financial overview and discussion led by the contracting pharmacist.
Ask specific questions of the double-blinded participants during a 15-minute Q&A session after the P&T meeting concludes.